Metabolic parameters of [¹⁸F]FDG PET-CT before and after radiotherapy may predict survival and recurrence in cervical cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zeng Q, Cai W, et al. Trends of cervical cancer at global, regional, and national level: data from the global burden of disease study 2019. BMC Public Health. 2021;21(1):894.
   PubMed Web of Science ®Google Scholar
• Bhatla N, Berek JS, Cuello Fredes M, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019;145(1):129–135.
   PubMed Web of Science ®Google Scholar
• Marth C, Landoni F, Mahner S, et al. Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv72–iv83.
   PubMed Web of Science ®Google Scholar
• Gandy N, Arshad MA, Park WE, et al. FDG-PET imaging in cervical cancer. Semin Nucl Med. 2019;49(6):461–470.
   PubMed Web of Science ®Google Scholar
• Pak K, Cheon GJ, Nam HY, et al. Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis. J Nucl Med. 2014;55(6):884–890.
   PubMed Web of Science ®Google Scholar
• Sharma A, Mohan A, Bhalla AS, et al. Role of various metabolic parameters derived from baseline 18F-FDG PET/CT as prognostic markers in non-small cell lung cancer patients undergoing platinum-based chemotherapy. Clin Nucl Med. 2018;43(1):e8–e17.
   PubMed Web of Science ®Google Scholar
• Im HJ, Pak K, Cheon GJ, et al. Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging. 2015;42(2):241–251.
   PubMed Web of Science ®Google Scholar
• Nie K, Zhang YX, Nie W, et al. Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: a systematic review and meta-analysis. J Med Imaging Radiat Oncol. 2019;63(1):84–93.
   PubMed Web of Science ®Google Scholar
• Wen W, Piao Y, Xu D, et al. Prognostic value of MTV and TLG of (18)F-FDG PET in patients with stage I and II non-small-cell lung cancer: a meta-analysis. Contrast Media Mol Imaging. 2021;2021:7528971.
   PubMed Web of Science ®Google Scholar
• Han S, Kim H, Kim YJ, et al. Prognostic value of volume-based metabolic parameters of (18)F-FDG PET/CT in ovarian cancer: a systematic review and meta-analysis. Ann Nucl Med. 2018;32(10):669–677.
   PubMed Web of Science ®Google Scholar
• Kim YI, Lee HS, Choi JY. Prognostic significance of pretreatment 18F-FDG PET/CT volumetric parameters in patients With colorectal liver metastasis: a systematic review and meta-analysis. Clin Nucl Med. 2021;46(3):206–213.
   PubMed Web of Science ®Google Scholar
• Creff G, Devillers A, Depeursinge A, et al. Evaluation of the prognostic value of FDG PET/CT parameters for patients with surgically treated head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 2020;146(5):471–479.
   PubMed Web of Science ®Google Scholar
• Han S, Kim YJ, Woo S, et al. Prognostic value of volumetric parameters of pretreatment 18F-FDG PET/CT in esophageal cancer: a systematic review and meta-analysis. Clin Nucl Med. 2018;43(12):887–894.
   PubMed Web of Science ®Google Scholar
• Ayati N, Sadeghi R, Kiamanesh Z, et al. The value of (18)F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2021;48(2):428–448.
   PubMed Web of Science ®Google Scholar
• Han L, Wang Q, Zhao L, et al. A systematic review and meta-analysis of the prognostic impact of pretreatment fluorodeoxyglucose positron emission tomography/computed tomography parameters in patients with locally advanced cervical cancer treated with concomitant chemoradiotherapy. Diagnostics. 2021;11(7):1258.
   Web of Science ®Google Scholar
• Han S, Kim H, Kim YJ, et al. Prognostic value of volume-based metabolic parameters of (18)F-FDG PET/CT in uterine cervical cancer: a systematic review and meta-analysis. AJR Am J Roentgenol. 2018;211(5):1112–1121.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Han S, Kim YS, et al. Prognostic value of post-treatment 18F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis. J Gynecol Oncol. 2019;30(5):e66.
   PubMed Web of Science ®Google Scholar
• Von Elm E, Altman DG, Egger M, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–808.
   PubMed Web of Science ®Google Scholar
• Regionalt cancercentrum i samverkan. Nationellt Vårdprogram för Livmoderhalscancer och Vaginalcancer; Version: 2.1. [Internet]. Stockholm; 2020. [cited 2022-12-21]. Available from: https://kunskapsbanken.cancercentrum.se/globalassets/cancerdiagnoser/gynekologi/livmoderhalscancer/varprogram/nationellt-vardprogram-livmoderhalscancer-cervixcancer-vaginalcancer.pdf.
   Google Scholar
• Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2005;(3):CD002225.
   PubMed Web of Science ®Google Scholar
• Vale C, Tierney J, Stewart L, et al. Chemoradiotherapy for cervical cancer meta-analysis C. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26(35):5802–5812.
   PubMed Web of Science ®Google Scholar
• Bjurberg M, Kjellén E, Ohlsson T, et al. Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer. Int J Gynecol Cancer. 2009;19(9):1600–1605.
   PubMed Web of Science ®Google Scholar
• Capaldi DPI, Hristov DH, Kidd EA. Parametric response mapping of coregistered positron emission tomography and dynamic contrast enhanced computed tomography to identify radioresistant subvolumes in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2020;107(4):756–765.
   PubMed Web of Science ®Google Scholar
• Banks TI, von Eyben R, Hristov D, et al. Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response. Cancer Med. 2018;7(8):3642–3651.
   PubMed Web of Science ®Google Scholar
• Toita T, Nakano M, Higashi M, et al. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33(4):843–849.
   PubMed Web of Science ®Google Scholar
• Ogino I, Okamoto N, Andoh K, et al. Analysis of prognostic factors in stage IIB-IVA cervical carcinoma treated with radiation therapy: value of computed tomography. Int J Radiat Oncol Biol Phys. 1997;37(5):1071–1077.
   PubMed Web of Science ®Google Scholar